Clinical Trial: ctDNA in Subjects With Muscle-invasive Bladder Cancer Treated With Trimodality Therapy
Study Status: Completed
Recruit Status: RECRUITING
Condition: Bladder Cancer
Study Type: OBSERVATIONAL
Official Title: Pilot Study to Evaluate the Role for Circulating Tumor DNA (ctDNA) in Monitoring Subjects With Muscle-invasive Bladder Cancer Treated With Trimodality Therapy
Brief Summary:
The purpose of this prospective biospecimen collection study is to evaluate the feasibility of measuring circulating tumor DNA (ctDNA) in subjects with muscle-invasive bladder cancer (MIBC) treated with trimodality therapy consisting of a maximal transurethral resection of bladder tumor followed by radiation and concomitant chemotherapy.Cancer cells have unique genes that determine the characteristics of tumors, such as how they will respond to different treatments.The tumor tissue will be used to determine the…
Read more